Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
6,253
INR
|
+0.58%
|
|
+5.23%
|
+7.85%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
460,540
|
516,741
|
749,317
|
714,500
|
767,655
|
1,041,305
|
-
|
-
|
Enterprise Value (EV)
1 |
484,568
|
513,012
|
745,052
|
703,980
|
719,330
|
974,873
|
936,288
|
897,915
|
P/E ratio
|
24.5
x
|
26.6
x
|
39.2
x
|
30.4
x
|
17.1
x
|
19
x
|
18.3
x
|
18.4
x
|
Yield
|
0.72%
|
0.8%
|
0.55%
|
0.7%
|
0.87%
|
0.65%
|
0.7%
|
0.7%
|
Capitalization / Revenue
|
2.99
x
|
2.96
x
|
3.95
x
|
3.33
x
|
3.11
x
|
3.74
x
|
3.49
x
|
3.29
x
|
EV / Revenue
|
3.15
x
|
2.94
x
|
3.93
x
|
3.28
x
|
2.92
x
|
3.5
x
|
3.13
x
|
2.83
x
|
EV / EBITDA
|
14.2
x
|
11
x
|
15.7
x
|
13.7
x
|
11.1
x
|
12.1
x
|
11.1
x
|
10.6
x
|
EV / FCF
|
22.3
x
|
20.5
x
|
28.7
x
|
52.3
x
|
15.1
x
|
28.3
x
|
19.4
x
|
18.5
x
|
FCF Yield
|
4.48%
|
4.87%
|
3.48%
|
1.91%
|
6.61%
|
3.54%
|
5.15%
|
5.4%
|
Price to Book
|
3.28
x
|
3.33
x
|
4.29
x
|
3.76
x
|
3.33
x
|
3.77
x
|
3.22
x
|
2.81
x
|
Nbr of stocks (in thousands)
|
166,011
|
165,776
|
165,940
|
165,954
|
166,105
|
166,522
|
-
|
-
|
Reference price
2 |
2,774
|
3,117
|
4,516
|
4,305
|
4,622
|
6,253
|
6,253
|
6,253
|
Announcement Date
|
5/17/19
|
6/9/20
|
5/14/21
|
5/19/22
|
5/10/23
|
-
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
153,851
|
174,600
|
189,722
|
214,391
|
246,697
|
278,772
|
298,748
|
316,757
|
EBITDA
1 |
34,189
|
46,431
|
47,480
|
51,400
|
64,559
|
80,866
|
84,377
|
85,077
|
EBIT
1 |
18,933
|
28,470
|
31,977
|
34,277
|
52,057
|
66,340
|
69,272
|
70,028
|
Operating Margin
|
12.31%
|
16.31%
|
16.85%
|
15.99%
|
21.1%
|
23.8%
|
23.19%
|
22.11%
|
Earnings before Tax (EBT)
1 |
22,443
|
18,032
|
28,324
|
32,298
|
60,485
|
72,199
|
74,612
|
75,557
|
Net income
1 |
18,795
|
19,498
|
19,149
|
23,568
|
45,073
|
54,644
|
56,739
|
56,985
|
Net margin
|
12.22%
|
11.17%
|
10.09%
|
10.99%
|
18.27%
|
19.6%
|
18.99%
|
17.99%
|
EPS
2 |
113.1
|
117.4
|
115.1
|
141.7
|
270.9
|
329.4
|
341.9
|
340.2
|
Free Cash Flow
1 |
21,700
|
24,995
|
25,962
|
13,448
|
47,552
|
34,468
|
48,242
|
48,505
|
FCF margin
|
14.1%
|
14.32%
|
13.68%
|
6.27%
|
19.28%
|
12.36%
|
16.15%
|
15.31%
|
FCF Conversion (EBITDA)
|
63.47%
|
53.83%
|
54.68%
|
26.16%
|
73.66%
|
42.62%
|
57.17%
|
57.01%
|
FCF Conversion (Net income)
|
115.46%
|
128.19%
|
135.58%
|
57.06%
|
105.5%
|
63.08%
|
85.02%
|
85.12%
|
Dividend per Share
2 |
20.00
|
25.00
|
25.00
|
30.00
|
40.00
|
40.79
|
43.95
|
43.95
|
Announcement Date
|
5/17/19
|
6/9/20
|
5/14/21
|
5/19/22
|
5/10/23
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
---|
Net sales
1 |
57,632
|
53,197
|
54,368
|
52,154
|
63,057
|
67,700
|
63,152
|
67,384
|
68,802
|
72,148
|
70,210
|
73,976
|
75,960
|
77,487
|
EBITDA
1 |
15,572
|
12,018
|
12,980
|
9,238
|
18,944
|
20,562
|
15,955
|
20,450
|
19,915
|
20,180
|
18,953
|
-
|
-
|
-
|
EBIT
1 |
10,372
|
9,042
|
8,743
|
6,188
|
15,818
|
17,291
|
12,800
|
16,867
|
16,126
|
16,410
|
14,590
|
17,939
|
18,610
|
18,984
|
Operating Margin
|
18%
|
17%
|
16.08%
|
11.86%
|
25.09%
|
25.54%
|
20.27%
|
25.03%
|
23.44%
|
22.74%
|
20.78%
|
24.25%
|
24.5%
|
24.5%
|
Earnings before Tax (EBT)
1 |
12,681
|
9,709
|
2,483
|
14,655
|
16,111
|
16,346
|
13,291
|
18,463
|
19,134
|
18,257
|
14,508
|
-
|
-
|
-
|
Net income
1 |
9,920
|
7,065
|
875
|
11,876
|
11,128
|
12,471
|
9,601
|
14,025
|
14,800
|
13,789
|
11,825
|
-
|
-
|
-
|
Net margin
|
17.21%
|
13.28%
|
1.61%
|
22.77%
|
17.65%
|
18.42%
|
15.2%
|
20.81%
|
21.51%
|
19.11%
|
16.84%
|
-
|
-
|
-
|
EPS
2 |
59.65
|
42.48
|
5.260
|
71.40
|
66.89
|
74.95
|
57.68
|
84.22
|
88.78
|
82.68
|
52.00
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/29/21
|
1/28/22
|
5/19/22
|
7/28/22
|
10/28/22
|
1/25/23
|
5/10/23
|
7/26/23
|
10/27/23
|
1/30/24
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
24,028
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
3,729
|
4,265
|
10,520
|
48,325
|
66,432
|
105,017
|
143,390
|
Leverage (Debt/EBITDA)
|
0.7028
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
21,700
|
24,995
|
25,962
|
13,448
|
47,552
|
34,468
|
48,242
|
48,505
|
ROE (net income / shareholders' equity)
|
14.1%
|
13.2%
|
11.6%
|
13%
|
21.4%
|
20.6%
|
18.2%
|
16%
|
ROA (Net income/ Total Assets)
|
8.33%
|
8.52%
|
7.69%
|
8.39%
|
14.7%
|
15%
|
13.2%
|
11.5%
|
Assets
1 |
225,515
|
228,823
|
248,866
|
281,073
|
307,340
|
364,529
|
429,469
|
497,683
|
Book Value Per Share
2 |
845.0
|
935.0
|
1,052
|
1,145
|
1,387
|
1,659
|
1,942
|
2,227
|
Cash Flow per Share
2 |
173.0
|
180.0
|
215.0
|
169.0
|
354.0
|
290.0
|
384.0
|
404.0
|
Capex
1 |
7,000
|
4,846
|
9,741
|
14,660
|
11,323
|
14,796
|
15,351
|
15,852
|
Capex / Sales
|
4.55%
|
2.78%
|
5.13%
|
6.84%
|
4.59%
|
5.31%
|
5.14%
|
5%
|
Announcement Date
|
5/17/19
|
6/9/20
|
5/14/21
|
5/19/22
|
5/10/23
|
-
|
-
|
-
|
Last Close Price
6,253
INR Average target price
6,005
INR Spread / Average Target -3.97% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.85% | 12.49B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|